![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC25A17 |
Gene summary for SLC25A17 |
![]() |
Gene information | Species | Human | Gene symbol | SLC25A17 | Gene ID | 10478 |
Gene name | solute carrier family 25 member 17 | |
Gene Alias | PMP34 | |
Cytomap | 22q13.2 | |
Gene Type | protein-coding | GO ID | GO:0001561 | UniProtAcc | B4DU97 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10478 | SLC25A17 | P54T-E | Human | Esophagus | ESCC | 1.60e-07 | 1.68e-01 | 0.0975 |
10478 | SLC25A17 | P56T-E | Human | Esophagus | ESCC | 1.58e-09 | 1.21e+00 | 0.1613 |
10478 | SLC25A17 | P57T-E | Human | Esophagus | ESCC | 1.09e-09 | 2.59e-01 | 0.0926 |
10478 | SLC25A17 | P61T-E | Human | Esophagus | ESCC | 7.73e-19 | 4.27e-01 | 0.099 |
10478 | SLC25A17 | P62T-E | Human | Esophagus | ESCC | 5.13e-41 | 5.75e-01 | 0.1302 |
10478 | SLC25A17 | P65T-E | Human | Esophagus | ESCC | 1.58e-17 | 2.81e-01 | 0.0978 |
10478 | SLC25A17 | P74T-E | Human | Esophagus | ESCC | 9.87e-43 | 1.01e+00 | 0.1479 |
10478 | SLC25A17 | P75T-E | Human | Esophagus | ESCC | 2.53e-29 | 6.71e-01 | 0.1125 |
10478 | SLC25A17 | P76T-E | Human | Esophagus | ESCC | 2.55e-18 | 5.09e-01 | 0.1207 |
10478 | SLC25A17 | P79T-E | Human | Esophagus | ESCC | 2.99e-21 | 4.19e-01 | 0.1154 |
10478 | SLC25A17 | P80T-E | Human | Esophagus | ESCC | 3.26e-25 | 4.81e-01 | 0.155 |
10478 | SLC25A17 | P82T-E | Human | Esophagus | ESCC | 4.71e-10 | 5.30e-01 | 0.1072 |
10478 | SLC25A17 | P83T-E | Human | Esophagus | ESCC | 1.18e-54 | 1.36e+00 | 0.1738 |
10478 | SLC25A17 | P84T-E | Human | Esophagus | ESCC | 1.66e-07 | 3.33e-01 | 0.0933 |
10478 | SLC25A17 | P89T-E | Human | Esophagus | ESCC | 1.68e-27 | 1.48e+00 | 0.1752 |
10478 | SLC25A17 | P91T-E | Human | Esophagus | ESCC | 1.10e-14 | 9.38e-01 | 0.1828 |
10478 | SLC25A17 | P104T-E | Human | Esophagus | ESCC | 1.85e-03 | 3.91e-01 | 0.0931 |
10478 | SLC25A17 | P107T-E | Human | Esophagus | ESCC | 3.91e-40 | 8.01e-01 | 0.171 |
10478 | SLC25A17 | P126T-E | Human | Esophagus | ESCC | 1.40e-05 | 2.44e-01 | 0.1125 |
10478 | SLC25A17 | P127T-E | Human | Esophagus | ESCC | 1.26e-06 | 1.07e-01 | 0.0826 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001593117 | Esophagus | ESCC | nucleobase-containing compound transport | 162/8552 | 222/18723 | 9.87e-17 | 7.93e-15 | 162 |
GO:00193958 | Esophagus | ESCC | fatty acid oxidation | 69/8552 | 103/18723 | 9.95e-06 | 9.44e-05 | 69 |
GO:00344407 | Esophagus | ESCC | lipid oxidation | 71/8552 | 108/18723 | 2.00e-05 | 1.74e-04 | 71 |
GO:00090628 | Esophagus | ESCC | fatty acid catabolic process | 66/8552 | 100/18723 | 3.21e-05 | 2.66e-04 | 66 |
GO:00066318 | Esophagus | ESCC | fatty acid metabolic process | 217/8552 | 390/18723 | 4.21e-05 | 3.39e-04 | 217 |
GO:00066358 | Esophagus | ESCC | fatty acid beta-oxidation | 50/8552 | 74/18723 | 1.16e-04 | 8.04e-04 | 50 |
GO:00723297 | Esophagus | ESCC | monocarboxylic acid catabolic process | 74/8552 | 122/18723 | 6.03e-04 | 3.27e-03 | 74 |
GO:00442427 | Esophagus | ESCC | cellular lipid catabolic process | 121/8552 | 214/18723 | 8.63e-04 | 4.43e-03 | 121 |
GO:00442827 | Esophagus | ESCC | small molecule catabolic process | 201/8552 | 376/18723 | 1.35e-03 | 6.41e-03 | 201 |
GO:00302586 | Esophagus | ESCC | lipid modification | 116/8552 | 212/18723 | 4.90e-03 | 1.89e-02 | 116 |
GO:00160427 | Esophagus | ESCC | lipid catabolic process | 168/8552 | 320/18723 | 7.97e-03 | 2.84e-02 | 168 |
GO:001593114 | Oral cavity | OSCC | nucleobase-containing compound transport | 150/7305 | 222/18723 | 4.86e-18 | 5.04e-16 | 150 |
GO:00090627 | Oral cavity | OSCC | fatty acid catabolic process | 59/7305 | 100/18723 | 3.99e-05 | 3.48e-04 | 59 |
GO:00066317 | Oral cavity | OSCC | fatty acid metabolic process | 186/7305 | 390/18723 | 2.65e-04 | 1.69e-03 | 186 |
GO:00723296 | Oral cavity | OSCC | monocarboxylic acid catabolic process | 66/7305 | 122/18723 | 5.02e-04 | 2.95e-03 | 66 |
GO:00193957 | Oral cavity | OSCC | fatty acid oxidation | 57/7305 | 103/18723 | 5.58e-04 | 3.23e-03 | 57 |
GO:00344406 | Oral cavity | OSCC | lipid oxidation | 59/7305 | 108/18723 | 7.01e-04 | 3.89e-03 | 59 |
GO:00066357 | Oral cavity | OSCC | fatty acid beta-oxidation | 42/7305 | 74/18723 | 1.47e-03 | 7.09e-03 | 42 |
GO:00442826 | Oral cavity | OSCC | small molecule catabolic process | 174/7305 | 376/18723 | 2.25e-03 | 1.00e-02 | 174 |
GO:00442426 | Oral cavity | OSCC | cellular lipid catabolic process | 104/7305 | 214/18723 | 2.61e-03 | 1.15e-02 | 104 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa041467 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa0414612 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa041466 | Oral cavity | OSCC | Peroxisome | 47/3704 | 82/8465 | 9.01e-03 | 2.01e-02 | 1.03e-02 | 47 |
hsa0414611 | Oral cavity | OSCC | Peroxisome | 47/3704 | 82/8465 | 9.01e-03 | 2.01e-02 | 1.03e-02 | 47 |
hsa0414621 | Oral cavity | LP | Peroxisome | 33/2418 | 82/8465 | 1.48e-02 | 4.69e-02 | 3.03e-02 | 33 |
hsa0414631 | Oral cavity | LP | Peroxisome | 33/2418 | 82/8465 | 1.48e-02 | 4.69e-02 | 3.03e-02 | 33 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC25A17 | SNV | Missense_Mutation | c.585N>T | p.Lys195Asn | p.K195N | O43808 | protein_coding | tolerated(0.33) | benign(0.139) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SLC25A17 | SNV | Missense_Mutation | c.662A>G | p.Tyr221Cys | p.Y221C | O43808 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-3715-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
SLC25A17 | SNV | Missense_Mutation | rs371543259 | c.641N>T | p.Ala214Val | p.A214V | O43808 | protein_coding | tolerated(0.08) | possibly_damaging(0.746) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
SLC25A17 | SNV | Missense_Mutation | rs765118849 | c.197G>A | p.Arg66Gln | p.R66Q | O43808 | protein_coding | deleterious(0.03) | possibly_damaging(0.603) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SLC25A17 | SNV | Missense_Mutation | c.713N>C | p.Asn238Thr | p.N238T | O43808 | protein_coding | tolerated(0.28) | benign(0.012) | TCGA-F5-6702-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Chemotherapy | oxaliplatin | PD | |
SLC25A17 | deletion | Frame_Shift_Del | c.84delN | p.Leu30TrpfsTer42 | p.L30Wfs*42 | O43808 | protein_coding | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | |||
SLC25A17 | deletion | Frame_Shift_Del | c.84delN | p.Leu30TrpfsTer42 | p.L30Wfs*42 | O43808 | protein_coding | TCGA-AA-3950-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
SLC25A17 | deletion | Frame_Shift_Del | c.84delN | p.Leu30TrpfsTer42 | p.L30Wfs*42 | O43808 | protein_coding | TCGA-D5-6530-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |||
SLC25A17 | SNV | Missense_Mutation | novel | c.181N>T | p.Leu61Phe | p.L61F | O43808 | protein_coding | tolerated(0.32) | benign(0.022) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SLC25A17 | SNV | Missense_Mutation | rs372825776 | c.473G>A | p.Arg158His | p.R158H | O43808 | protein_coding | deleterious(0.02) | probably_damaging(0.93) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |